News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News ‘Smart’ Approach Wins for Post-PCI Antiplatelet Prescribing Yael L. Maxwell April 19, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021
News Daily News Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD Michael O'Riordan February 19, 2021
News Daily News Site Investigators Missed Clinical Events in GLOBAL LEADERS Michael O'Riordan February 12, 2021
News Daily News Experts Update Antithrombotic Advice in AF Patients Undergoing PCI Todd Neale February 09, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Daily News Primary PCI Underused but Just as Effective in Cancer Patients With STEMI Michael O'Riordan February 04, 2021
News Daily News Rivaroxaban-Aspirin Combo Works in ASCVD Across BMI Groups Todd Neale February 01, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020